Intercept Pharmaceuticals | DŁUG



DŁUG Zmiana Data
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amarin USD 0 0 2025-03
Amgen USD 54.59B 1.62B 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Incyte USD 40.41M 855K 2025-12
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Moderna USD 734M 7M 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
PTC Therapeutics USD 286.32M 306K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09


Intercept Pharmaceuticals DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.